Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• C. auris: ‘A nasty bug’ threatening US hospitals
• Addressing racial disparities in HIV care crucial to meeting US goals
• Experts call for change in FDA’s MSM blood donation ban
• HCV over 3 decades: From a disease with no name to a cure
• IDSA guidelines address health care–associated ventriculitis, meningitis
• Letermovir effective as prophylaxis for cytomegalovirus in high-risk hematopoietic cell transplant patients
• Media coverage of medical research often lacks expert commentary, disclosures
• NSAIDs may increase myocardial infarction risk during acute respiratory infections
• Oral cholera vaccine does not significantly increase risk of pregnancy loss
• Potential FDA pick favors approving drugs before efficacy demonstrated
• Researchers warn of mcr-1 spread as China OKs colistin use in humans
• Viral outbreak linked to rats spreads to nine US states, Canada
• Zika vaccine may not be available until 2020
• What caused C. auris to emerge on several continents around the same time?
• Remember risk-benefits of DAAs still lean heavily toward the benefits Douglas T. Dieterich, MD; Ira M. Jacobson, MD
• Nontuberculous mycobacteria: Pathogens of growing importance Matthew E. Levison, MD, FACP; Donald Kaye, MD, MACP
• Current methods for cleaning endoscopes not always effective
• Exposure to patients with influenza persists despite hospital surveillance
• First global analysis of neonatal herpes reveals 14,000 cases occur annually
• Freeze-dried FMT capsules effectively treat recurrent C. difficile infection
• HAV outbreak in Israel traced to IV drug use
• HCV prevalence lower in Iran vs. other Middle Eastern countries
• Higher doses of daptomycin associated with lower mortality among VRE patients
• Implementing vector control strategies in cattle sheds may eliminate malaria in India
• Infection most common cause for 30-day hospitalization after prostate biopsy
• Low–birth-weight infants with early-onset candidiasis have a poorer prognosis
• Mucormycosis-related hospitalizations double since 2000
• New clinical details revealed about first newborn to survive Ebola virus
• Patients with HIV may have increased risk for diabetes
• Researchers link increase in syphilis cases to highly active ART
• Study explores cost, effectiveness of M. bovis interventions in Morocco
• Surotomycin inferior to vancomycin for C. difficile
• Survey: Most HIV care providers do not prescribe PrEP
• Seniors who receive high-dose influenza vaccine experience more side effects
• VA antibiotic use falls by 12% under national antimicrobial stewardship program
• ART, male circumcision drives down HIV incidence in Uganda
• HIV-HCV coinfection eradication possible in France by 2026
• Increased treatment of MSM leads to decrease in acute HCV in the Netherlands
• New HIV infections decline 18% in US
• New HIV integrase inhibitor shows promise in phase 2 trial
• New TB regimens promise to simplify, shorten therapy
• ‘On-demand’ PEP reduces incidence of chlamydia, syphilis in MSM
• Oral PrEP protective in women with bacterial vaginosis
• Prednisone reduces TB-IRIS risk in patients with HIV
• Two-drug HIV regimen noninferior to multidrug regimen
• Study supports that HIV reservoir lies in cells infected before ART initiation
• Zika RNA persists in serum longer than dengue, West Nile
• Antiviral switch strategy in HIV: The role of dual regimens Jeff Brock, PharmD, MBA, BCIDP